Avinash Bajaj

46PUBLICATIONS
69CO-AUTHORS
Medical infection agents (incl. prions)Tissue engineeringMolecular targetsGlycoconjugatesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Jan 08, 2026
A Biologically Inert Tamoxifen-derived Long-lasting Hydrogel-mediated Immunochemotherapy Can Mitigate Tumour Progression and Activate T Cell Immunity.

Somesh Kumar Jha, Sandeep Kumar, Dolly Jain

|Nov 20, 2025
Localized Hydrogel-Mediated Docetaxel-Carboplatin Combination Chemotherapy Targets Ganglioside Metabolism to Mitigate Tumor Progression.

Mohammad Nafees Ansari, Jasleen Kaur, Ali Khan

|Sep 14, 2025
Aspirin-Conjugated Cholic Acid Derivative Combats Polymicrobial Infections and Inflammation.

Sayed M Safwan, Devashish Mehta, Varsha Saini

|Aug 14, 2025
Ponatinib Averts αCD40 Antibody Mediated Toxicity by Lowering MAPK38 Expression and Shows Proimmunogenic Effects in a Murine Tumor Model.

Vidit Gaur, Anjali Barnwal, Khushboo Singh

|May 13, 2025
Recent Advances in the Development of Antifungal Agents: Beyond Azoles, Polyenes, and Echinocandins.

Varsha Saini, Sayed M Safwan, Devashish Mehta

Pageof 8